Mukka Proteins
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Mukka Proteins received an EU Inputs Attestation from ECOCERT S.A.S. of France for its Eco Sphere Organic Fertilizer, confirming its suitability for organic farming under specified programme conditions. The attestation was issued under EU Regulations 2018/848 and 2021/1165 and ran from September 4, 2026 to March 31, 2028. Fish protein remained the company’s core business, with exports accounting for more than 65% and FY26 operating revenue at about ₹1,450 crore. The company had been developing a broader portfolio spanning alternate protein, waste-to-value and frozen or value-added marine products.
Powered by Tijori
Mukka Proteins received an EU Inputs Attestation from ECOCERT S.A.S. of France for its Eco Sphere Organic Fertilizer, confirming its suitability for organic farming under specified programme conditions. The attestation was issued under EU Regulations 2018/848 and 2021/1165 and ran from September 4, 2026 to March 31, 2028. Fish protein remained the company’s core business, with exports accounting for more than 65% and FY26 operating revenue at about ₹1,450 crore. The company had been developing a broader portfolio spanning alternate protein, waste-to-value and frozen or value-added marine products.
Powered by Tijori
Mukka Proteins approved a strategic investment of up to ₹13.19 crore in Shipwaves Online, a digital freight-forwarding and enterprise SaaS company. The investment involved 2.932 crore equity shares at ₹4.50 each and was set to give Mukka Proteins a 16.77% stake, with completion scheduled by 31 March 2027 in one or more tranches. Shipwaves reported FY26 turnover of ₹65.01 crore, profit after tax of ₹1.68 crore and net worth of ₹71.30 crore. The transaction was related-party because Mukka Proteins was a promoter-group entity of Shipwaves, and it was to be conducted at arm’s length. Mukka Proteins reported FY26 consolidated revenue of ₹1,449.5 crore, with fish protein as its core business and exports accounting for more than 65% of revenue.
Powered by Tijori
Mukka Proteins approved a strategic investment of up to ₹13.19 crore in Shipwaves Online, a digital freight-forwarding and enterprise SaaS company. The investment involved 2.932 crore equity shares at ₹4.50 each and was set to give Mukka Proteins a 16.77% stake, with completion scheduled by 31 March 2027 in one or more tranches. Shipwaves reported FY26 turnover of ₹65.01 crore, profit after tax of ₹1.68 crore and net worth of ₹71.30 crore. The transaction was related-party because Mukka Proteins was a promoter-group entity of Shipwaves, and it was to be conducted at arm’s length. Mukka Proteins reported FY26 consolidated revenue of ₹1,449.5 crore, with fish protein as its core business and exports accounting for more than 65% of revenue.
Powered by Tijori
Mukka Proteins received in-principle approvals from NSE and BSE on August 28 for a proposed preferential issue of convertible warrants. The approvals covered 2 crore warrants of Re. 1 each at ₹23.50 a warrant, implying an aggregate issue value of ₹47 crore to non-promoter investors. The board approved the warrant proposal in June, and the company submitted applications for exchange clearance that month. FY26 consolidated revenue was ₹1,449.5 crore, while year-end inventory and current borrowings were ₹856.6 crore and ₹735.7 crore.
Powered by Tijori
Mukka Proteins received in-principle approvals from NSE and BSE on August 28 for a proposed preferential issue of convertible warrants. The approvals covered 2 crore warrants of Re. 1 each at ₹23.50 a warrant, implying an aggregate issue value of ₹47 crore to non-promoter investors. The board approved the warrant proposal in June, and the company submitted applications for exchange clearance that month. FY26 consolidated revenue was ₹1,449.5 crore, while year-end inventory and current borrowings were ₹856.6 crore and ₹735.7 crore.
Powered by Tijori
Mukka Proteins received relief from the CESTAT Bangalore Regional Bench, which set aside a quantified customs demand of ₹15.24 crore together with unquantified interest, redemption fine and penalties. The dispute concerned fish-meal imports made between September 2014 and October 2015 under the Advance Authorisation Scheme, which customs authorities had alleged were undervalued and misdeclared. The tribunal held that the department had not established undervaluation with cogent evidence and allowed the company's appeal and those of three other appellants. The company may seek a refund of ₹75 lakh appropriated under the original order, subject to statutory procedure. Mukka Proteins had revenue of ₹1,450 crore and net profit of ₹57 crore in FY26.
Powered by Tijori
Mukka Proteins received relief from the CESTAT Bangalore Regional Bench, which set aside a quantified customs demand of ₹15.24 crore together with unquantified interest, redemption fine and penalties. The dispute concerned fish-meal imports made between September 2014 and October 2015 under the Advance Authorisation Scheme, which customs authorities had alleged were undervalued and misdeclared. The tribunal held that the department had not established undervaluation with cogent evidence and allowed the company's appeal and those of three other appellants. The company may seek a refund of ₹75 lakh appropriated under the original order, subject to statutory procedure. Mukka Proteins had revenue of ₹1,450 crore and net profit of ₹57 crore in FY26.
Powered by Tijori
Mukka Proteins' board approved the preferential allotment of up to 2 crore fully convertible warrants at ₹23.50 each to 15 non-promoter investors, raising up to ₹47 crore. Each warrant is convertible into one equity share within 18 months, and the issue price is based on a registered valuer's report. The board also cleared two acquisitions: a 51% stake in Delta Marine Products for up to ₹11.1 crore and a 51% stake in Aqua Marine for up to ₹15 crore, both fish meal and fish oil manufacturers. Delta Marine reported a loss of ₹19.7 lakh on revenue of ₹28.2 crore in FY25, while Aqua Marine posted a profit of ₹10.7 lakh on revenue of ₹32.2 crore. The investments are aimed at expanding Mukka's core business and production capacity.
Powered by Tijori
Mukka Proteins' board approved the preferential allotment of up to 2 crore fully convertible warrants at ₹23.50 each to 15 non-promoter investors, raising up to ₹47 crore. Each warrant is convertible into one equity share within 18 months, and the issue price is based on a registered valuer's report. The board also cleared two acquisitions: a 51% stake in Delta Marine Products for up to ₹11.1 crore and a 51% stake in Aqua Marine for up to ₹15 crore, both fish meal and fish oil manufacturers. Delta Marine reported a loss of ₹19.7 lakh on revenue of ₹28.2 crore in FY25, while Aqua Marine posted a profit of ₹10.7 lakh on revenue of ₹32.2 crore. The investments are aimed at expanding Mukka's core business and production capacity.
Powered by Tijori
May 15 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - APPROVES FUND RAISING UP TO 250 MILLION RUPEES VIA NCDS
MUKKA PROTEINS LTD - APPROVES FUND RAISING UP TO 500 MILLION RUPEES VIA NCDS
MUKKA PROTEINS MARCH-QUARTER CONSOL NET PROFIT 206.2 MILLION RUPEES
MUKKA PROTEINS MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 3.81 BILLION RUPEES
Source text: ID:nBSE5cfSwr
Further company coverage: MUKK.NS
(([email protected];))
May 15 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - APPROVES FUND RAISING UP TO 250 MILLION RUPEES VIA NCDS
MUKKA PROTEINS LTD - APPROVES FUND RAISING UP TO 500 MILLION RUPEES VIA NCDS
MUKKA PROTEINS MARCH-QUARTER CONSOL NET PROFIT 206.2 MILLION RUPEES
MUKKA PROTEINS MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 3.81 BILLION RUPEES
Source text: ID:nBSE5cfSwr
Further company coverage: MUKK.NS
(([email protected];))
Aug 14 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS- EMPANELLED AS AUTHORISED WASTE PROCESSOR BY BENGALURU SOLID WASTE MANAGEMENT
MUKKA PROTEINS LTD - TO MANAGE 200-300 MTPD OF WASTE, EXPANDING TO 1,000 TPD
Source text: ID:nNSE1BdD07
Further company coverage: MUKK.NS
(([email protected];;))
Aug 14 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS- EMPANELLED AS AUTHORISED WASTE PROCESSOR BY BENGALURU SOLID WASTE MANAGEMENT
MUKKA PROTEINS LTD - TO MANAGE 200-300 MTPD OF WASTE, EXPANDING TO 1,000 TPD
Source text: ID:nNSE1BdD07
Further company coverage: MUKK.NS
(([email protected];;))
March 26 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - ACQUIRES 51% STAKE IN FABBCO
MUKKA PROTEINS LTD - ACQUISITION VALUED AT 60 MILLION RUPEES
Source text: ID:nNSE3vt2jl
Further company coverage: MUKK.NS
(([email protected];))
March 26 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - ACQUIRES 51% STAKE IN FABBCO
MUKKA PROTEINS LTD - ACQUISITION VALUED AT 60 MILLION RUPEES
Source text: ID:nNSE3vt2jl
Further company coverage: MUKK.NS
(([email protected];))
** Shares of Mukka Proteins MUKK.NS rise 6% to 35 rupees, their biggest one-day gain in more than two months
** The fish oil maker wins multiple orders worth 442.8 million rupees ($5.09 million) for supplying fish meal and oil
** More than 937,000 shares traded, 1.7x the 30-day avg
** Still, MUKK stock trades below 50-, 100-, 200- day moving avgs
** Stock down ~13% since its listing in March 2024
** Stock down 15% so far this year
($1 = 87.0150 Indian rupees)
(Reporting by Aleef Jahan in Bengaluru)
** Shares of Mukka Proteins MUKK.NS rise 6% to 35 rupees, their biggest one-day gain in more than two months
** The fish oil maker wins multiple orders worth 442.8 million rupees ($5.09 million) for supplying fish meal and oil
** More than 937,000 shares traded, 1.7x the 30-day avg
** Still, MUKK stock trades below 50-, 100-, 200- day moving avgs
** Stock down ~13% since its listing in March 2024
** Stock down 15% so far this year
($1 = 87.0150 Indian rupees)
(Reporting by Aleef Jahan in Bengaluru)
Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - RECEIVES PURCHASE ORDERS WORTH 442.8 MILLION RUPEES
Source text: ID:nNSEbkL7ll
Further company coverage: MUKK.NS
Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - RECEIVES PURCHASE ORDERS WORTH 442.8 MILLION RUPEES
Source text: ID:nNSEbkL7ll
Further company coverage: MUKK.NS
Dec 17 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - COMPLETION OF DISINVESTMENT IN MSFI (BANGLADESH)
Source text: ID:nBSEcgj1bt
Further company coverage: MUKK.NS
(([email protected];))
Dec 17 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - COMPLETION OF DISINVESTMENT IN MSFI (BANGLADESH)
Source text: ID:nBSEcgj1bt
Further company coverage: MUKK.NS
(([email protected];))
Oct 21 (Reuters) - Mukka Proteins Ltd MUKK.NS:
APPROVED ISSUANCE OF SHARES WORTH 980 MILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: MUKK.NS
(([email protected];;))
Oct 21 (Reuters) - Mukka Proteins Ltd MUKK.NS:
APPROVED ISSUANCE OF SHARES WORTH 980 MILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: MUKK.NS
(([email protected];;))
Oct 14 (Reuters) - Mukka Proteins Ltd MUKK.NS:
TO CONSIDER RAISING OF FUNDS
Source text for Eikon: ID:nBSE3c19wk
Further company coverage: MUKK.NS
(([email protected];;))
Oct 14 (Reuters) - Mukka Proteins Ltd MUKK.NS:
TO CONSIDER RAISING OF FUNDS
Source text for Eikon: ID:nBSE3c19wk
Further company coverage: MUKK.NS
(([email protected];;))
Sept 30 (Reuters) - Mukka Proteins Ltd MUKK.NS:
EXECUTION OF AGREEMENT FOR DISINVESTMENT IN MSFI (BANGLADESH)
DEAL FOR USD 14,038.44
Source text for Eikon: [ID:]
Further company coverage: MUKK.NS
(([email protected];;))
Sept 30 (Reuters) - Mukka Proteins Ltd MUKK.NS:
EXECUTION OF AGREEMENT FOR DISINVESTMENT IN MSFI (BANGLADESH)
DEAL FOR USD 14,038.44
Source text for Eikon: [ID:]
Further company coverage: MUKK.NS
(([email protected];;))
April 1 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - GETS ORDER WORTH 503.9 MILLION RUPEES
Source text for Eikon: ID:nBSEbjZxt9
Further company coverage: MUKK.NS
(([email protected];;))
April 1 (Reuters) - Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD - GETS ORDER WORTH 503.9 MILLION RUPEES
Source text for Eikon: ID:nBSEbjZxt9
Further company coverage: MUKK.NS
(([email protected];;))
Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD- RECEIPT OF PURCHASE ORDERS WORTH OF 152.5 MILLION RUPEES
Source text for Eikon: ID:nNSE3B1480
Further company coverage: MUKK.NS
Mukka Proteins Ltd MUKK.NS:
MUKKA PROTEINS LTD- RECEIPT OF PURCHASE ORDERS WORTH OF 152.5 MILLION RUPEES
Source text for Eikon: ID:nNSE3B1480
Further company coverage: MUKK.NS
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Mukka Proteins do?
Mukka Proteins is engaged in the business of manufacturing of Fish Protein (i.e. fish meal, fish oil and fish soluble paste) and Insect Protein (i.e. insect meal and insect oil), which is an essential ingredient in the manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). It sells its products domestically and also exports them to many countries.
Who are the competitors of Mukka Proteins?
Mukka Proteins major competitors are Chemkart India. Market Cap of Mukka Proteins is ₹877 Crs. While the median market cap of its peers are ₹219 Crs.
Is Mukka Proteins financially stable compared to its competitors?
Mukka Proteins seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Mukka Proteins pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Mukka Proteins latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Mukka Proteins allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory
How strong is Mukka Proteins balance sheet?
Balance sheet of Mukka Proteins is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Mukka Proteins improving?
Yes, profit is increasing. The profit of Mukka Proteins is ₹72.56 Crs for TTM, ₹52.06 Crs for Mar 2026 and ₹46.46 Crs for Mar 2025.
Is the debt of Mukka Proteins increasing or decreasing?
Yes, The net debt of Mukka Proteins is increasing. Latest net debt of Mukka Proteins is ₹649 Crs as of Mar-26. This is greater than Mar-25 when it was ₹366 Crs.
Is Mukka Proteins stock expensive?
Mukka Proteins is not expensive. Latest PE of Mukka Proteins is 12.69, while 3 year average PE is 18.28. Also latest EV/EBITDA of Mukka Proteins is 10.7 while 3yr average is 14.37.
Has the share price of Mukka Proteins grown faster than its competition?
Mukka Proteins has given better returns compared to its competitors. Mukka Proteins has grown at ~-3.49% over the last 1yrs while peers have grown at a median rate of -4.15%
Is the promoter bullish about Mukka Proteins?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Mukka Proteins is 73.33% and last quarter promoter holding is 73.33%.
Are mutual funds buying/selling Mukka Proteins?
There is Insufficient data to gauge this.